- Investing Ideas
- Hong Kong Pharmaceuticals & Biotech Potentially Undervalued Small Caps
Hong Kong Pharmaceuticals & Biotech Potentially Undervalued Small Caps
Results
3
Value score of at least 4 focused on companies with a low market cap.
3 companies
Austar Lifesciences
Market Cap: HK$348.6m
An investment holding company, provides integrated engineering solutions to pharmaceutical manufacturers and research institutes in Mainland China and internationally.
6118
HK$0.70
7D
1.4%
1Y
-35.2%
Kontafarma China Holdings
Market Cap: HK$167.7m
An investment holding company, manufactures and sells chemical drugs, active pharmaceutical ingredients (API), and API intermediates in Mainland China, Singapore, Taiwan, and internationally.
1312
HK$0.03
7D
0%
1Y
3.4%
Shenzhen Neptunus Interlong Bio-technique
Market Cap: HK$203.0m
Engages in the research and development, manufacturing, and selling of medicines and medical devices in the People’s Republic of China.
8329
HK$0.12
7D
-2.4%
1Y
-30.1%